Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04198792
Other study ID # GES
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 1, 2010
Est. completion date January 1, 2030

Study information

Verified date May 2024
Source Sahlgrenska University Hospital, Sweden
Contact Bengt Redfors, MD, PhD
Phone +46768445402
Email bengt.redfors@vgregion.se
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In ECPR, where CPR times often range from 30 to 120 minutes, only patients with good circulation during CPR survive, while non-survivors commonly suffer from anoxic brain injury. The selection process during CPR is challenging causing a general survival rate of just 2 out of 10, and the urgent need for better selection criteria has been emphasized. It it crucial to keep cardiac arrest times as short as possible, pre primed-ECMO can facilitate this. The ECMO treatment and the long CPR times of ECPR can also affect the measurements of the neurologic prognostication guidelines after cardiac arrest, making its validity uncertain in this specific cohort. Further, the long-term neuropsychological follow-up is limited to a few patients, making it uncertain if ECPR gives the survivors good long-term life satisfaction or just a prolonged life. Our overall aim is to optimize and improve the care pathway for ECPR patients by refining patient selection, assessing pre-primed ECMO, validating neurological prognostication guidelines, and understanding long-term outcomes and challenges faced by survivors. Specific Aim 1: Evaluating predictors for good neurological outcomes in ECPR and to develop an evidence-based selection tool for ECPR. Specific aim 2: To assess the sterility and function of pre-primed ECMO. Specific aim 3: To evaluate the applicability of current guidelines for neurological prognostication after cardiac arrest in ECPR patients, and to assess the predictive value of individual and combined neurological tests in this specific patient population. Specific aim 4: To determine the long-term neuropsychological outcomes, identify the problems survivors experience in daily life, and assess life satisfaction - by comprehensive follow-up visits with validated questionnaires and neuropsychology testing up to 10 years after the ECMO-treated cardiac arrest


Description:

Specific aim 1: Patients from the Gothenburg ECPR cohort are included in the study. Possible predictors for good neurological outcomes are prospectively gathered. The predictive ability of the predictors for good neurological outcome is tested in univariate and multivariable analysis, with the aim of improving patient selection for ECPR. Specific aim 2: Cardiohelp ECMO circuits are set up dry, followed by wet-priming and used in the ECMO treatments of the centre. The circuits are cultured at ECMO-initiation and the incidence of positive cultures is assessed. The effect of the pre-primed time on ECMO function is also assessed. Specific aim 3: The predictive ability of the current guideline for neurological prognostication of comatose patients in the ICU after cardiac arrest, from the European Resuscitation Council, is assessed in the ECPR cohort of Gothenburg. The diagnostic performance of individual predictors as well as the total accuracy of the prediction will be assessed. Specific aim 4: Long-term follow-up will be assessed for the ECPR patients, to determine the long-term neuropsychological outcomes, identify the problems survivors experience in daily life, and assess life satisfaction. QUALY will be calculated. The general ECMO population from 2004 of the center is included as a control group and positive cultures during their ECMO runs are documented.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date January 1, 2030
Est. primary completion date January 1, 2030
Accepts healthy volunteers No
Gender All
Age group 16 Years and older
Eligibility Inclusion Criteria: - ECMO-treated patients att Sahlgrenska University Hospital Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
No intervention, but ECPR patients will be compared to ECMO-patients that have not had cardiac arrest

Locations

Country Name City State
Sweden Sahlgrenska Akademy at Sahlgrenska University Hospital Gothenburg

Sponsors (1)

Lead Sponsor Collaborator
Sahlgrenska University Hospital, Sweden

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Other Cost The in hospital cost of the treatment for the patients, in Swedish kronor. 3 month
Primary Survival with Cerebral Performance Category 1 or 2. Good neurological outcome in ECPR-patients 1 year
Primary Physicians Global Assessment to measure quality of life Quality of Life in survivors after ECPR and ECMO without cardiac arrest, Measured with in depth interviews 1-15 years
Primary Positive blood Cultures Infection rates in ECMO-patients 1 month
Primary Euro Qualy - 5 dimension (EQ-5D) Assesment of quality of life 1-7 years
Primary Cerebral Performance Scale (CPC) Assessment of cerebral performance. 1-5, where 1-2 is considered good outcome 1-7 years
Primary Modified Rankin scale (MRs) Assessmenty of cognitive function. 0-6, where 0 is best. 1-7 years
Primary Trailmaking test Assessmenty of cognitive function. Shorter time is better. 1-7 years
Primary Short Form -36 (SF-36) Quality of life. 8 scaled scores from 0-100, where 100 is best. 1-7 years
Primary New York heart association class (NYHA class) Assessment of physical function.1-4, where 1 is best 1-7 years
Primary Positive cultures of pre-primed ECMO circuits ECMO circuits is pre-primed and cultures taken at the start of ECMO treatment 0-90 days
Primary Performance of ECMO oxygenator function Oxygenator resistance, and the needed FiO2 and sweep gas flow will be assessed 0-60 days
Primary Predictive ability of ERC neuro prognostication guidelines on ECPR patients Diagnostic performance and ROC analysis of individual and total ERC predictors on outcome in ECPR 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT06048068 - Removing Surrogates' Uncertainty to Reduce Fear and Anxiety After Cardiac Events N/A
Recruiting NCT05558228 - Accuracy of Doppler Ultrasound Versus Manual Palpation of Pulse in Cardiac Arrest
Completed NCT03685383 - Cytokine Adsorption in Post-cardiac Arrest Syndrome in Patients Requiring Extracorporeal Cardiopulmonary Resuscitation N/A
Completed NCT04619498 - Effectiveness of an Interactive Cognitive Support Tablet App to Improve the Management of Pediatric Cardiac Arrest N/A
Completed NCT04584645 - A Digital Flu Intervention for People With Cardiovascular Conditions N/A
Not yet recruiting NCT05649891 - Checklists Resuscitation Emergency Department N/A
Withdrawn NCT02352350 - Lactate in Cardiac Arrest N/A
Completed NCT03024021 - Cerebral Oxymetry and Neurological Outcome in Therapeutic Hypothermia
Completed NCT02247947 - Proteomics to Identify Prognostic Markers After CPR and to Estimate Neurological Outcome
Completed NCT02275234 - Care After Resuscitation
Completed NCT01936597 - Prospective Study of 3 Phone Assistance Strategies to Achieve a Continuous Cardiac Massage N/A
Completed NCT01972087 - Simulation Training to Improve 911 Dispatcher Identification of Cardiac Arrest N/A
Completed NCT01944605 - Intestinal Ischemia as a Stimulus for Systemic Inflammatory Response After Cardiac Arrest N/A
Active, not recruiting NCT01239420 - Norwegian Cardio-Respiratory Arrest Study
Completed NCT00878644 - Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-OH [Out of Hospital] Trial Phase 3
Completed NCT01191736 - Ultra-Brief Versus Brief Hands Only CPR Video Training With and Without Psychomotor Skill Practice N/A
Completed NCT00880087 - Therapeutic Hypothermia to Improve Survival After Cardiac Arrest in Pediatric Patients-THAPCA-IH [In Hospital] Trial N/A
Completed NCT00729794 - Vasopressin, Epinephrine, and Steroids for Cardiac Arrest Phase 3
Recruiting NCT00441753 - Cerebral Bloodflow and Carbondioxide Reactivity During Mild Therapeutic Hypothermia in Patients After Cardiac Arrest N/A
Completed NCT00347477 - Fluid Shifts in Patients Treated With Therapeutic Hypothermia After Cardiac Arrest Phase 3